Cite

HARVARD Citation

    Krishna, R. et al. (n.d.). 1575A 28-day high-dose safety and pharmacokinetics study of raltegravir in healthy subjects. Open forum infectious diseases. pp. S419-S420. [Online]. 
  
Back to record